Live Breaking News & Updates on Zach Herschfus

Stay updated with breaking news from Zach herschfus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Oramed to Present at the 83rd American Diabetes Association Conference

/PRNewswire/ Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), announced today that it has been selected to present an oral abstract. ....

United States , San Diego , San Diego Convention Center , Zach Herschfus , Oramed Pharmaceuticals Nasdaq , Prnewswire Oramed Pharmaceuticals Inc , Company Contact , Oramed Pharmaceuticals , Oramed Pharmaceuticals Inc , American Diabetes Association , Exchange Commission , Scientific Sessions , Oral Insulin Alleviates Liver Fibrosis , Reduces Fat , Metabolic Liver Disease , From Bench , Protein Oral Delivery , Annual Report , Quarterly Reports , Oramed Pharmaceuticals Inc ,

Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit

/PRNewswire/ Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), announced today that Chief Scientific Officer Dr. Miriam Kidron will. ....

United States , Miriam Kidron , Zach Herschfus , Oramed Pharmaceuticals , Prnewswire Oramed Pharmaceuticals Inc , Oramed Pharmaceuticals Nasdaq , Company Contact , Oramed Pharmaceuticals Inc , Chief Scientific Officer , Novel Therapies , Obesity Summit , Hyatt Regency Boston , Protein Oral Delivery , Oramed Pharmaceuticals Inc , Health Care Amp Hospitals , Medical Pharmaceuticals , Pharmaceuticals , Computer Amp Electronics , Computer Software , Trade Show News ,

Oramed Announces that its Chinese Partner, HTIT, has Successfully Completed a Phase 3 Oral Insulin Clinical Trial and Submitted a Marketing Authorization Application in China

Oramed has completed an analysis of its U.S.-based Phase 3 oral insulin trial with significant lowering of A1C levels seen in patient subgroups
NEW YORK, May 15, 2023 /PRNewswire/ Oramed. | May 15, 2023 ....

United States , Zach Herschfus , Nadav Kidron , Oramed Pharmaceuticals Nasdaq , Oramed Pharmaceuticals , Prnewswire Oramed Pharmaceuticals Inc , Company Contact , Oramed Pharmaceuticals Inc , Hefei Tianhui Biotechnology Co Ltd , Exchange Commission , National Medical Products Administration , Hefei Tianhui Biotechnology , Oramed Chief Executive Officer , Protein Oral Delivery , Methodology Used , Annual Report , Quarterly Reports , Oramed Pharmaceuticals Inc Stock Exchange , Press Release , 023 Oju1 Us68403p2039 ,

Oramed Appoints Ben Shapiro to its Board of Directors

/PRNewswire/ Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP) ("Oramed" or the "Company") (www.oramed.com) announced today the appointment of Mr. Benjamin. ....

New York , United States , Ben Shapiro , Nadav Kidron , Zach Herschfus , Benjamin Shapiro , Oramed Pharmaceuticals Inc , New York Times , Prnewswire Oramed Pharmaceuticals Inc , Harvard Law School , Exchange Commission , Company Contact , Oramed Pharmaceuticals , Oramed Pharmaceuticals Nasdaq , Nasdaq Capital , Daily Wire , Ben Shapiro Show , Political Science , Oramed Chief Executive Officer , Protein Oral Delivery , Annual Report , Quarterly Reports ,

Oramed Appoints Ben Shapiro to its Board of Directors

NEW YORK, May 1, 2023 /PRNewswire/ Oramed Pharmaceuticals Inc. announced today the appointment of Mr. Benjamin Shapiro to its Board of Directors effective May 1, 2023. The Board determined. | May 1, 2023 ....

New York , United States , Ben Shapiro , Nadav Kidron , Zach Herschfus , Benjamin Shapiro , Oramed Pharmaceuticals Nasdaq , Oramed Pharmaceuticals , Company Contact , Exchange Commission , Harvard Law School , Prnewswire Oramed Pharmaceuticals Inc , New York Times , Oramed Pharmaceuticals Inc , Nasdaq Capital , Daily Wire , Ben Shapiro Show , Political Science , Oramed Chief Executive Officer , Protein Oral Delivery , Annual Report , Quarterly Reports , Oramed Pharmaceuticals Inc Stock Exchange , Press Release , Oard Ormp Us68403p2039 ,